Sangamo Biosciences (SGMO) Misses Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
Revenue Growth %: -5.7%
Financial Fact:
Total revenues: 2.82M
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: -5.7%
Financial Fact:
Total revenues: 2.82M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Sangamo Biosciences (NASDAQ: SGMO) reported Q3 EPS of ($0.27), $0.02 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $2.8 million versus the consensus estimate of $4.24 million.
For earnings history and earnings-related data on Sangamo Biosciences (SGMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
- UBS Reiterates Buy Rating on General Motors (GM) as Defense Opportunity in Focus
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
